Old Web
English
Sign In
Acemap
>
authorDetail
>
Leni van Doorn
Leni van Doorn
Erasmus University Medical Center
Medicine
Nausea
Internal medicine
Neutropenia
Febrile neutropenia
4
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sunitinib-induced blood pressure rise does not involve aldosterone: observations in a patient after bilateral adrenalectomy
2018
Journal of Hypertension
Jorie Versmissen
Leni van Doorn
Katrina M. Mirabito Colafella
Ron H.J. Mathijssen
A.H. Jan Danser
Show All
Source
Cite
Save
Citations (2)
Abstract A92: A phase 1 safety and pharmacokinetic study of navitoclax in combination with docetaxel in patients with solid tumors.
2011
Molecular Cancer Therapeutics
F. Eskens
Martin Gutierrez
David Cosgrove
M. Puglisi
Leni van Doorn
M. Blanco
Maja J.A. de Jonge
Kirsty Moran
Axel Walther
Jianning Yang
Todd Busman
C. Franklin
Mack Mabry
Rod A. Humerickhouse
Lulama Rhoda Molife
Show All
Source
Cite
Save
Citations (0)
Abstract A15: A phase I and pharmacokinetic study of the vascular disrupting agent AVE8062 in combination with docetaxel, administered once every 3 weeks to patients with advanced solid tumors
2009
Molecular Cancer Therapeutics
Patricia Tresca
Diego Tosi
Leni van Doorn
Hélène Fontaine
Ate van der Gaast
Christine Veyrat‐Follet
Corina Oprea
V. Diéras
F. Eskens
Show All
Source
Cite
Save
Citations (0)
First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: A phase II study
2007
British Journal of Cancer
E. van Meerten
F. Eskens
E C van Gameren
Leni van Doorn
A. van der Gaast
Show All
Source
Cite
Save
Citations (39)
1